Browse diseases

…y pretreated patients across multiple tumor types, particularly HNSCC, with a manageable safety profile. Therefore, exploring the com…

…proved responses to immunotherapy across multiple cancer types. Head and neck squamous cell carcinoma (HNSCC) has frequent amplification of the SWI/SNF subunit ACTL6A, which…

…ansion study is evaluating CHS-114 in advanced solid tumors and head and neck squamous cell carcinoma (HNSCC). CHS-114 has demonstrated an acceptable safety profile …

…e absence of HPV-specific T cells in CESC.Conclusions Unlike in HNSCC, the composition of TLSs, rather than their quantity, was assoc…

…assessment characterizing the immunopeptidome of 10 HNSCC and 3 NSCLC cell lines derived from 9 different patients, revealed 74,578 u…

…unique samples. Compared to HPV+ oropharynx tumors, oral cavity HNSCC had significantly higher proportions of NK cells (p = 0.02), an…

…y; MDADI, MD Anderson Dysphagia Inventory; ND, neck dissection; OPC, oropharyngeal cancer; RT, radiotherapy; SIB, Simultaneous Inte…

…revolutionized treatment outcomes for advanced cancers, notably melanoma, NSCLC, RCC, urothelial carcinoma, and HNSCC. 1 2 By antagonizi…

…and memory B cells, plasmablasts and plasma cells in TIL-B high OSCC. In tumors enriched for plasmablasts, heterogeneous expression …

…sions TU2218 in combination with Pembrolizumab in patients with HNSCC demonstrated high response rate and manageable toxicity support…

…lanatory value in the pathogenesis of CSCC. Comparing CSCC with head and neck squamous cell carcinoma (HNSCC)—which shares histology but responds poorly to PD-1 inhibitors—m…

… immune defense against both viral infections and malignancies. Head and neck squamous cell carcinomas (HNSCC) rank among the most common cancers worldwide, with a poor 5-yea…